Paul Gross Net Worth
Paul Gross Net Worth As of August 1, 2024, Paul Gross has an estimated net worth of approximately $1,475. He is currently listed as See Remarks at Clovis Oncology Inc and holds around 98,330 shares of Clovis Oncology Inc (CLVSQ), which are valued at over $1,475. These details are based on the most recent data available as of November 2, 2022.
Disclaimer: The insider information provided is based on SEC filings. The estimated net worth assumes that Paul Gross has not conducted any transactions since November 2, 2022, and still holds the reported stocks.
Paul Gross Insider Ownership Reports
Paul Gross's insider ownership is documented through SEC filings. According to these reports, he owns stock in one company: Clovis Oncology Inc (CLVSQ).
Summary of Insider Ownership by Paul Gross
| Ticker | Company | Date of Last Transaction | Type of Owner |
|---|---|---|---|
| CLVSQ | Clovis Oncology Inc | 2022-11-02 | See Remarks |
Overview of Paul Gross’s Current Holdings
As of November 2, 2022, Paul Gross owns a total of 98,330 shares in Clovis Oncology Inc (CLVSQ). The current valuation of these shares is approximately $1,475 based on the most recent stock price.
| Ticker | Company | Date of Last Transaction | Number of Shares | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLVSQ | Clovis Oncology Inc | 2022-11-02 | 98,330 | 0.02 | 1,475 |
Detailed Look at Paul Gross’s Financial Involvement
Paul Gross’s financial stake in Clovis Oncology Inc is significant due to his large shareholding. Clovis Oncology Inc (ticker: CLVSQ) is a biopharmaceutical company dedicated to developing innovative treatments for cancer. His ownership of nearly 100,000 shares suggests a strong belief in the company’s potential.
Understanding Insider Trading and SEC Reports
Insider trading refers to the buying or selling of company stock by individuals with confidential, material information about the company. Executives, directors, and employees are required to report their trades to the Securities and Exchange Commission (SEC). These reports are filed using Form 4, which provides details on the insider’s transactions and current holdings.
Importance of Paul Gross’s Holdings
Paul Gross’s significant investment in Clovis Oncology Inc may indicate several strategic insights:
- Belief in Company Growth: His substantial shareholding suggests confidence in the company’s future performance and potential for growth.
- Influence on Company Decisions: As a major shareholder, Gross likely has a considerable impact on the company’s strategic direction and decisions.
- Long-Term Investment View: The fact that he has held these shares since November 2022 reflects a long-term investment strategy, which can be reassuring to other investors.
About Clovis Oncology Inc (CLVSQ)
Clovis Oncology Inc is a biopharmaceutical firm focused on creating new treatments for cancer. The company aims to improve cancer care by developing targeted therapies for various types of cancer.
Company Mission and Achievements
The mission of Clovis Oncology is to enhance cancer treatment through innovative drug development. The company has made significant progress in its drug development programs, contributing to advancements in cancer therapy.
Future Outlook and Market Position
Clovis Oncology’s future looks promising, with ongoing research and development efforts focused on new therapies. The company’s market position benefits from its commitment to innovation and potential new drug approvals.
Effect of Insider Trading on Investor Perception
Insider trading activities are closely watched by investors as they provide insight into the confidence levels of a company’s top executives. When insiders like Paul Gross hold onto their shares, it often signals optimism about the company's future, which can positively influence other investors and impact the stock price.
- Janelle Stelson Net Worth
- Andre Hakkak Net Worth 2024
- Rickey Smiley Net Worth 2024
- Brandon Fugal Net Worth 2024
- Ryan Ashley Net Worth
Conclusion
Paul Gross’s estimated net worth of $1,475 and his substantial ownership in Clovis Oncology Inc highlight his significant investment and trust in the company's future. Analyzing his insider trading activities offers valuable insights for investors and stakeholders regarding the company's prospects.